Overall Status

Completed (12)

Recruiting (7)

Active, not recruiting (3)

Not yet recruiting (2)

Unknown status (2)

Withdrawn (2)

Terminated (1)

Phase

n/a (8)

phase 1 (6)

phase 2 (5)

phase 3 (4)

phase 1/phase 2 (1)

Study Documents

Intervention Type

drug (15)

procedure (4)

behavioral (3)

device (3)

other (3)

biological (2)

radiation (1)

Funder Type

Other (20)

Industry (9)

Study Type

Interventional (24)

Observational (5)

malignant neoplasm of breast

Showing 26 - 29 of 29

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Cancer, Malignant Tumor of Breast, Malignant Tumors of Bone and Articular Cartilage Trial (Lenvatinib, Capecitabine)

Withdrawn

Advanced Cancer
+13 more

(no location specified)

Jun 23, 2017

HER-2 Positive Breast Cancer, Malignant Tumor of Breast Trial in Meldola (Lapatinib, Caelyx)

Terminated

HER-2 Positive Breast Cancer
Malignant Neoplasm of Breast

Lapatinib, Caelyx

Meldola, FC, Italy

UO Oncologia medica, IRCCS IRST

Feb 1, 2016

Cancer Stem Cells Using iFP Technique

Unknown status

Malignant Neoplasm of Breast
+2 more

Haifa, Israel

Rambam Health Care Campus

Jul 11, 2012

Malignant Tumor of Breast Trial in Tuebingen (ICG Fluorescence technique)

Unknown status

Malignant Neoplasm of Breast

ICG Fluorescence technique

Tuebingen, Germany

University Department of Gynecology and Obstetrics

Jul 15, 2011